Contrary to popular belief, curing a disease can be more economically valuable than relying on ongoing monthly treatments. Recent findings show that a one-time cure, achieving the same patient outcomes without recurring prescriptions, can offer over twice the financial return. Chief Futurist Brett Winton covers more on The Brainstorm.
|
Deepwater's Gene Munster joins 'Fast Mon...
CNBC's Kristina Partsinevelos joins the ...
CNBC's Emily Wilkins joins 'Fast Money' ...
CNBC’s Andrew Ross Sorkin breaks down th...
Dr. Mani Foroohar, Leerink Partners, joi...
Alcoa CEO William Oplinger joins 'Closin...
GORは、明治安田生命保険グループ、三菱UFJフィナンシャル・グループ、近鉄グル...
Bloomberg’s Caroline Hyde and Ed Ludlow ...
Apple plans to revamp Siri later this ye...
Chips startup Neurophos has closed a $11...
Jeff Bezos' Blue Origin marks a successf...
日経CNBC「攻めのIR Vol.290 テラテクノロジー株式会社」(提供:SB...
当社は、ゲームソフトを中心とするソフトウェア開発のグローバルBPOパートナーです...